Literature DB >> 26761587

Tissue factor-positive monocytes expression in children with sickle cell disease: clinical implication and relation to inflammatory and coagulation markers.

Seham M Ragab1, Mohamed A Soliman.   

Abstract

Hemostatic abnormalities are well documented in sickle cell disease (SCD). Nevertheless, whether these perturbations could contribute to sickle vasculopathy is still not clear. We evaluated monocytes tissue factor (TF) expression in children with SCD correlating the results with the clinical state and some inflammatory and coagulation markers. The study included 24 children with SCD in steady state, 24 in painful crisis and 20 healthy age and sex-matched children as controls. Complete blood count, prothrombin time (%), activated partial thromboplastin time, fibrinogen, D-dimer, thrombin-antithrombin complex and quantitative C-reactive protein were assayed. TF expression on monocytes was analyzed by flow cytometry. TF-positive monocytes were significantly higher in both patient groups compared with the controls, being higher in painful crisis group (2.06 ± 0.64, 8.01 ± 1.53, 13.5 ± 4.3 for the controls, steady state and painful crisis groups, respectively). Among painful crisis group, TF expression on monocytes was positively correlated with the pain rate, reticulocytes (%) and three out of six markers of inflammation and coagulation (C-reactive protein, D-dimer and fibrinogen) with inverse correlation with hemoglobin and the red blood cells count. TF-positive monocytes were more expressed in SCD both in steady state and in painful crisis, being significantly higher in painful crisis. This expression was significantly related to the pain rate as well as to markers of hemolysis, inflammation and coagulation among patients in painful crisis. These results confirm the substantial role played by TF-positive monocytes in the pathogenesis of SCD painful crisis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26761587     DOI: 10.1097/MBC.0000000000000494

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

Review 1.  Sickle cell disease: an inherited thrombophilia.

Authors:  Ted Wun; Ann Brunson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 2.  How I diagnose and treat venous thromboembolism in sickle cell disease.

Authors:  Arun S Shet; Ted Wun
Journal:  Blood       Date:  2018-05-15       Impact factor: 22.113

3.  A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.

Authors:  Anna Solovey; Arif Somani; John D Belcher; Liming Milbauer; Lucile Vincent; Rafal Pawlinski; Karl A Nath; Robert J Kelm; Nigel Mackman; M Gerard O'Sullivan; Kalpna Gupta; Gregory M Vercellotti; Robert P Hebbel
Journal:  Am J Hematol       Date:  2017-07-29       Impact factor: 10.047

Review 4.  Innate immune cells, major protagonists of sickle cell disease pathophysiology.

Authors:  Slimane Allali; Thiago Trovati Maciel; Olivier Hermine; Mariane de Montalembert
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

5.  The molecular basis for the prothrombotic state in sickle cell disease.

Authors:  Arun S Shet; Maria A Lizarralde-Iragorri; Rakhi P Naik
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.